A detailed history of Sih Partners, Lllp transactions in Alkermes Plc. stock. As of the latest transaction made, Sih Partners, Lllp holds 10,234 shares of ALKS stock, worth $318,686. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,234
Holding current value
$318,686
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$28.08 - $36.0 $287,370 - $368,424
10,234 New
10,234 $338 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $5.11B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Sih Partners, Lllp Portfolio

Follow Sih Partners, Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sih Partners, Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Sih Partners, Lllp with notifications on news.